Trade Ideas
Actionable trade ideas with entry/stop/target and risk framing.
Philips (PHG) - Buy the AI-Enabled Healthcare Momentum; Tactical Long with Defined Stops
Macro backdrop favors durable demand in imaging and monitoring; recent AI M&A + device connectivity trends create re-rating opportunities
Koninklijke Philips is parked at the intersection of steady healthcare demand and an accelerating AI upgrade cycle in imaging and intravascular diagno...
Carvana: Proof in the P&L — Trade the Profitability Inflection
Retail used-car leader is finally producing consistent profits; trade the momentum with defined risk.
Carvana (CVNA) has moved from a growth-at-any-cost story to sustained profitability across recent quarters. The business is generating positive net in...
Ring Energy (REI) - A Low-Priced, Cash-Flowing Oil E&P with a Real Path to Debt Paydown
Strong operating cash flow in 2025 supports measured financing activity; trade the recovery while watching non-operating swings
Ring Energy is generating meaningful operating cash flow through 2025 while executing bolt-on M&A in the Permian. Recent financing outflows and repeat...
Buy the Dip in Freedom Holding (FRHC): Tactical Long with Defined Risk/Reward
Strong cash generation and improving operating income make the recent pullback a compelling trade — size carefully, expect volatility.
Freedom Holding Corp. (FRHC) is a diversified brokerage and banking holding company with heavy exposure to emerging Eurasian markets. Recent quarters ...
High-Risk, High-Reward: Long Annexon Ahead of C1q-Targeted Readouts
Small-cap biotech with a cash runway squeeze turned manageable after a $75M raise; ANNX is a binary clinical bet on C1q inhibition—trade small, size for optionality.
Annexon (ANNX) is a clinical-stage biotech developing C1q-targeted therapies across autoimmune, neurodegenerative, and ophthalmic indications. With pi...
Kiniksa: Arcalyst Fuels the Business, KPL-387 Could Turbocharge the Re-rating
Long idea: buy the revenue-backed biotech with a clinical-stage accelerator—entry 40-44, stop 34, target 58/75
Kiniksa is trading like a growth biotech but with a commercial engine. Arcalyst (rilonacept) is delivering sequential revenue and profitability; cash ...
Uber: Underappreciated Platform Value — A Tactical Long with Defined Risk/Reward
Strong cash generation, improving operating profits and a large asset base make UBER a buy on weakness into catalysts; disciplined entry, stop and targets recommended.
Uber is trading below what its operating performance and asset base justify. Recent quarterly results show accelerating revenue and predictable cash f...
United States Antimony: Execution-Dependent Growth; A Risky but Actionable Long
Ramp-up capital spending, strong equity cushion, and critical-minerals tailwinds - trade it as a high-conviction, execution-dependent swing/position long.
United States Antimony (UAMY) is mid-ramp: management is spending aggressively to expand production and diversify into zeolites while maintaining mini...
SentinelOne: Cash-Rich Cybersecurity Growth at a 4x Forward Sales Multiple — Trade Plan
Revenue near-term growth ~20% with improving operating losses makes S a tactical long at ~4x forward sales
SentinelOne is trading around $14 with an implied market cap near $4.7B. Using the latest two-quarter annualized revenue and management's recent top-l...
Kinetik Holdings: Buy the Yield, Own the Permian Optionality
High single-digit dividend today, pipeline optionality over the next 12-24 months - actionable long with defined stops and upside targets.
Kinetik (KNTK) is a Permian-focused midstream owner-operator offering a roughly 8.1% cash yield today and steady operating cash flow. Strong quarterly...
Regeneron Pre-Quarter: Why Q4 Should Beat and 2026 Looks Like a Re-acceleration
Entry at ~750, stop ~680, targets 900/1,000 — a position trade based on product momentum, cash flow, and a clean balance sheet.
Regeneron enters its Q4 print with solid top-line momentum (Q3 revenue $3.75B), heavy operating cash flow, and a tidy balance sheet. I expect a quarte...
KMI Trade Idea: Buy the Dip — Natural Gas Cash Flow + AI Data‑Center Demand
High cash flow, steady dividend and an overlooked AI demand vector make Kinder Morgan a pragmatic long with defined risk limits.
Kinder Morgan (KMI) is a cash-generative midstream operator with stable pipeline volumes, improving operating cash flow and a growing narrative tying ...